Teva Pharmaceuticals USA, Inc. et al v. MYLAN Pharmaceuticals Inc. et al
Teva Pharmaceuticals USA, Inc., Teva Pharmaceutical Industries Ltd., Yeda Research and Development Co. Ltd. and TEVA Neuroscience, Inc. |
MYLAN Pharmaceuticals Inc., MYLAN Inc. and Natco Pharma Ltd. |
1:2010cv07246 |
September 20, 2010 |
US District Court for the Southern District of New York |
Foley Square Office |
XX Out of State |
Katherine B Forrest |
Patent |
35 U.S.C. § 271 |
None |
Docket Report
This docket was last retrieved on November 28, 2017. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 88 SEALED MATERIALS DISPOSED: Document(s) 65 were destroyed since the filing party did not retrieve the material(s) within 30 days of the date indicated. The sealed record(s) were destroyed on 11/28/2017.(mps) |
Filing 87 NOTICE TO ATTORNEY TO RETRIEVE SEALED MATERIAL: Notice to the attorney of record for the filing party to retrieve sealed document number 65 within thirty (30) days, or the Court will dispose of them. Sealed Records Retrieval due by 11/24/2017. (mps) |
Appeal Fee Refunded: for #83 Notice of Appeal,,. Filing fee refunded for Receipt number 0208-8797466, for the following reason(s): INCORRECT FILING. (dig) |
Filing 86 MANDATE of USCA FOR THE FEDERAL CIRCUIT (Certified Copy) as to #84 Notice of Appeal to the Federal Circuit, filed by Teva Pharmaceutical Industries Ltd., Yeda Research and Development Co. Ltd., TEVA Neuroscience, Inc., Teva Pharmaceuticals USA, Inc. USCA Case Number 13-1573. It is hereby ORDERED that the proceeding is DISMISSED pursuant to Rule 42(b) of the Federal Rules of Appellate Procedure. Jan Horbaly, Clerk USCA for the Federal Circuit. Issued As Mandate: 9/5/2013. (nd) |
Filing 85 NOTICE OF DOCKETING from U.S. Court of Appeals for the Federal Circuit: USCA Case Number 13-1573 from the US Court of Appeals, Federal Circuit assigned to #84 Notice of Appeal to the Federal Circuit, filed by Teva Pharmaceutical Industries Ltd., Yeda Research and Development Co. Ltd., TEVA Neuroscience, Inc., Teva Pharmaceuticals USA, Inc.. (nd) |
Transmission of Notice of Appeal and Certified Copy of Docket Sheet to US Court of Appeals for the Federal Circuit, re: #84 Notice of Appeal to the Federal Circuit. (nd) |
Filing 84 NOTICE OF APPEAL TO THE FEDERAL CIRCUIT from #81 Clerk's Judgment, #80 Memorandum & Opinion,,. Form 7 and Form 22 are due within 14 days. Document filed by TEVA Neuroscience, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Yeda Research and Development Co. Ltd.. Filing fee $ 455.00, receipt number 0208-8797624. (Hashmall, David) |
Filing 83 FILING ERROR - WRONG EVENT TYPE SELECTED FROM MENU - NOTICE OF APPEAL from #81 Clerk's Judgment, #80 Memorandum & Opinion,,. Document filed by TEVA Neuroscience, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Yeda Research and Development Co. Ltd.. Filing fee $ 455.00, receipt number 0208-8797466. Form C and Form D are due within 14 days to the Court of Appeals, Second Circuit. (Hashmall, David) Modified on 8/20/2013 (nd). |
|
Set/Reset Deadlines: Motions due by 8/16/2013. (mro) |
Filing 81 CLERK'S JUDGMENT; That for the reasons stated in the Court's Opinion and Order dated July 15, 2013, the motions to dismiss brought by defendants Mylan, Natco, and Sandoz are granted in their entirety and these actions 09 Civ. 10112 and 10 Civ. 7246 are terminated. (Signed by Clerk of Court Ruby Krajick on 7/19/2013) (Attachments: #1 Notice of Right to Appeal)(dt) |
|
Transmission to Judgments and Orders Clerk. Transmitted re: #80 Memorandum & Opinion, to the Judgments and Orders Clerk. (mro) |
|
|
|
Filing 76 MOTION for Nicholas K. Mitrokostas to Appear Pro Hac Vice. Filing fee $ 200.00, receipt number 0208-8543113. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by TEVA Neuroscience, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc.. (Attachments: #1 Proposed Order)(Mitrokostas, Nicholas) |
>>>NOTICE REGARDING PRO HAC VICE MOTION. Regarding Document No. #76 MOTION for Nicholas K. Mitrokostas to Appear Pro Hac Vice. Filing fee $ 200.00, receipt number 0208-8543113. Motion and supporting papers to be reviewed by Clerk's Office staff.. The document has been reviewed and there are no deficiencies. (bcu) |
|
|
|
|
Minute Entry for proceedings held before Judge Katherine B. Forrest: Oral Argument held on 5/13/2013. (jp) |
|
|
>>>NOTICE REGARDING PRO HAC VICE MOTION. Regarding Document No. #69 MOTION for Henry C. Dinger to Appear Pro Hac Vice. Filing fee $ 200.00, receipt number 0208-8433973. Motion and supporting papers to be reviewed by Clerk's Office staff.. The document has been reviewed and there are no deficiencies. (bcu) |
Filing 69 MOTION for Henry C. Dinger to Appear Pro Hac Vice. Filing fee $ 200.00, receipt number 0208-8433973. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by TEVA Neuroscience, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc.. (Attachments: #1 Proposed Order)(Dinger, Henry) |
Filing 68 REPLY MEMORANDUM OF LAW in Support re: #58 MOTION to Dismiss.. Document filed by Natco Pharma Ltd.. (Bloodworth, Shannon) |
Filing 67 DECLARATION of David L. Anstaett in Support re: #60 MOTION to Dismiss.. Document filed by MYLAN Inc., MYLAN Pharmaceuticals Inc.. (Attachments: #1 Exhibit 1)(Bloodworth, Shannon) |
Filing 66 REPLY MEMORANDUM OF LAW in Support re: #60 MOTION to Dismiss.. Document filed by MYLAN Inc., MYLAN Pharmaceuticals Inc.. (Bloodworth, Shannon) |
Filing 65 SEALED DOCUMENT placed in vault.(nm) |
Filing 64 NOTICE of Materials Filed Under Seal. Document filed by TEVA Neuroscience, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Yeda Research and Development Co. Ltd.. (Hashmall, David) |
Filing 63 MEMORANDUM OF LAW in Opposition re: #58 MOTION to Dismiss.. Document filed by TEVA Neuroscience, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Yeda Research and Development Co. Ltd.. (Hashmall, David) |
Filing 62 DECLARATION of David L. Anstaett in Support re: #60 MOTION to Dismiss.. Document filed by MYLAN Inc., MYLAN Pharmaceuticals Inc.. (Attachments: #1 Exhibit Exhibit 1, #2 Exhibit Exhibit 2, #3 Exhibit Exhibit 3, #4 Exhibit Exhibit 4, #5 Exhibit Exhibit 5, #6 Exhibit Exhibit 6, #7 Exhibit Exhibit 7)(Bloodworth, Shannon) |
Filing 61 MEMORANDUM OF LAW in Support re: #60 MOTION to Dismiss.. Document filed by MYLAN Inc., MYLAN Pharmaceuticals Inc.. (Bloodworth, Shannon) |
Filing 60 MOTION to Dismiss. Document filed by MYLAN Inc., MYLAN Pharmaceuticals Inc.. Responses due by 4/5/2013 Return Date set for 4/17/2013 at 11:59 PM.(Bloodworth, Shannon) |
Filing 59 MEMORANDUM OF LAW in Support re: #58 MOTION to Dismiss.. Document filed by Natco Pharma Ltd.. (Bloodworth, Shannon) |
Filing 58 MOTION to Dismiss. Document filed by Natco Pharma Ltd.. Responses due by 4/5/2013 Return Date set for 4/17/2013 at 11:59 PM.(Bloodworth, Shannon) |
|
|
|
|
Filing 53 NOTICE OF CASE REASSIGNMENT to Judge Katherine B. Forrest. Judge Barbara S. Jones is no longer assigned to the case. (pgu) |
|
|
Filing 50 NOTICE of WITHDRAWAL OF COUNSEL. Document filed by TEVA Neuroscience, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Yeda Research and Development Co. Ltd.. (Jean, Patrice) |
|
CASE NO LONGER REFERRED to Magistrate Judge Andrew J. Peck. I have closed the above reference for magistrate judge statistical purposes. Reason: Return to D.J. (Case Stayed). (jab) |
|
Filing 47 AMENDED CLAIM CONSTRUCTION STATEMENT. Document filed by MYLAN Inc., MYLAN Pharmaceuticals Inc., Natco Pharma Ltd., TEVA Neuroscience, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Yeda Research and Development Co. Ltd..(Hassett, Annemarie) |
Filing 46 JOINT STIPULATION that the deadline to file and serve the parties' opening claim construction briefs and supporting materials is extended to 5/20/11. Expert depositions may be held between 6/17 and 7/15/11, and as further set forth in this document. (Signed by Magistrate Judge Andrew J. Peck on 5/10/11) (cd) |
Filing 45 JOINT CLAIM CONSTRUCTION STATEMENT. Document filed by MYLAN Inc., MYLAN Pharmaceuticals Inc., TEVA Neuroscience, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Yeda Research and Development Co. Ltd..(Hassett, Annemarie) |
Filing 44 NOTICE OF APPEARANCE by Annemarie Hassett on behalf of TEVA Neuroscience, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc. (Hassett, Annemarie) |
Filing 43 ENDORSED LETTER addressed to Magistrate Judge Andrew J. Peck from John T. Bennett dated 3/31/2011 re: Counsel writes to request that the Court quash the subpoena served upon Dr. Johnson and limit the scope of another third party subpoena served upon W.R. Grace & Co. ENDORSEMENT: 1. The Court will allow the Court whose subpoenas are at issue, the District of Maryland, to rule on the scope of the subpoenas. 2. However, to remove any incentive on the parties to use the deposition testimony or documents (and ESI) for purposes of the 09 Civ. 8824 case, this Court now rules that nothing learned from the depositions or documents can be used in 09 Civ. 8824. If after the D.Md. court rules, there is any other issue for this Court, either side may raise it with this Court. (Signed by Magistrate Judge Andrew J. Peck on 4/1/2011) (tro) Modified on 4/4/2011 (tro). |
|
|
CASHIERS OFFICE REMARK on #40 Motion to Appear Pro Hac Vice in the amount of $25.00, paid on 01/18/2011, Receipt Number 925845. (jd) |
CASHIERS OFFICE REMARK on 40 Motion to Appear Pro Hac Vice in the amount of $25.00, paid on 01/18/2011, Receipt Number 925845. (jd) |
Filing 40 MOTION for Daryl L. Wiesen to Appear Pro Hac Vice. Document filed by TEVA Neuroscience, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc..(mbe) |
|
Filing 38 REPLY MEMORANDUM OF LAW in Support re: #25 MOTION to Dismiss.. Document filed by Natco Pharma Ltd.. (Solano, Ricardo) |
Filing 37 DECLARATION of Ricardo Solano Jr. in Support re: #21 MOTION to Dismiss.. Document filed by MYLAN Inc., MYLAN Pharmaceuticals Inc.. (Attachments: #1 Exhibit 1)(Solano, Ricardo) |
Filing 36 REPLY MEMORANDUM OF LAW in Support re: #21 MOTION to Dismiss.. Document filed by MYLAN Inc., MYLAN Pharmaceuticals Inc.. (Solano, Ricardo) |
|
CASHIERS OFFICE REMARK on 28 Motion to Appear Pro Hac Vice in the amount of $25.00, paid on 12/15/2010, Receipt Number 923641. (jd) |
CASHIERS OFFICE REMARK on #28 Motion to Appear Pro Hac Vice in the amount of $25.00, paid on 12/15/2010, Receipt Number 923641. (jd) |
Filing 34 SEALED DOCUMENT placed in vault.(nm) |
Filing 33 DECLARATION of Joseph B. Crystal in Support of Plaintiffs' Memorandum of Law in Opposition to Defendants Mylan Pharmaceuticals Inc. and Mylan Inc.'s Motion to Dismiss (FILED UNDER SEAL). Document filed by TEVA Neuroscience, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc.. (Attachments: #1 Exhibit 1, #2 Exhibit 2)(Hashmall, David) |
Filing 32 MEMORANDUM OF LAW in Opposition re: #25 MOTION to Dismiss.. Document filed by TEVA Neuroscience, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Yeda Research and Development Co. Ltd.. (Hashmall, David) |
Filing 31 NOTICE of Materials Filed Under Seal. Document filed by TEVA Neuroscience, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Yeda Research and Development Co. Ltd.. (Hashmall, David) |
|
Filing 29 NOTICE OF APPEARANCE by Joseph B. Crystal on behalf of TEVA Neuroscience, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc. (Crystal, Joseph) |
Filing 28 MOTION for John T. Bennett to Appear Pro Hac Vice. Document filed by TEVA Neuroscience, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc..(mbe) |
CASHIERS OFFICE REMARK on #16 Order Admitting Attorney Pro Hac Vice, in the amount of $175.00, paid on 11/16/2010, Receipt Number 921466. (jd) |
CASHIERS OFFICE REMARK on 16 Order Admitting Attorney Pro Hac Vice, in the amount of $175.00, paid on 11/16/2010, Receipt Number 921466. (jd) |
Filing 27 DECLARATION of Ricardo Solano Jr. in Support re: #25 MOTION to Dismiss.. Document filed by Natco Pharma Ltd.. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5)(Solano, Ricardo) |
Filing 26 MEMORANDUM OF LAW in Support re: #25 MOTION to Dismiss.. Document filed by Natco Pharma Ltd.. (Solano, Ricardo) |
Filing 25 MOTION to Dismiss. Document filed by Natco Pharma Ltd..(Solano, Ricardo) |
Filing 24 RULE 7.1 CORPORATE DISCLOSURE STATEMENT. No Corporate Parent. Document filed by Natco Pharma Ltd..(Solano, Ricardo) |
Filing 23 DECLARATION of Ricardo Solano Jr. in Support re: #21 MOTION to Dismiss.. Document filed by MYLAN Inc., MYLAN Pharmaceuticals Inc.. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5)(Solano, Ricardo) |
Filing 22 MEMORANDUM OF LAW in Support re: #21 MOTION to Dismiss.. Document filed by MYLAN Inc., MYLAN Pharmaceuticals Inc.. (Solano, Ricardo) |
Filing 21 MOTION to Dismiss. Document filed by MYLAN Inc., MYLAN Pharmaceuticals Inc..(Solano, Ricardo) |
Filing 20 RULE 7.1 CORPORATE DISCLOSURE STATEMENT. No Corporate Parent. Document filed by MYLAN Inc., MYLAN Pharmaceuticals Inc..(Solano, Ricardo) |
|
Transmission to Sealed Records Clerk. Transmitted re: 19 Stipulation and Order, Set Deadlines/Hearings, to the Sealed Records Clerk for the sealing or unsealing of document or case. (jpo) |
Transmission to Sealed Records Clerk. Transmitted re: #19 Stipulation and Order, Set Deadlines/Hearings, to the Sealed Records Clerk for the sealing or unsealing of document or case. (jpo) |
Filing 18 TRANSCRIPT of proceedings held on November 4, 2010 at 10:00 a.m. before Magistrate Judge Andrew J. Peck. (js) |
Filing 17 TRANSCRIPT of proceedings held on November 4, 2010 10:00 a.m. before Magistrate Judge Andrew J. Peck. (ajc) |
|
|
Minute Entry for proceedings held before Magistrate Judge Andrew J. Peck: Scheduling Conference held on 11/4/2010, ( Discovery (Fact) due by 6/1/2011 and Discovery (Expert) due by 10/28/2011., Status Conference set for 1/12/2011 at 02:00 PM before Magistrate Judge Andrew J. Peck.). (mbe) |
Filing 14 NOTICE OF APPEARANCE by Andrew Levine on behalf of MYLAN Inc., MYLAN Pharmaceuticals Inc., Natco Pharma Ltd. (Levine, Andrew) |
Filing 13 NOTICE OF APPEARANCE by Ricardo Solano, Jr on behalf of MYLAN Inc., MYLAN Pharmaceuticals Inc., Natco Pharma Ltd. (Solano, Ricardo) |
Filing 12 NOTICE OF APPEARANCE by Carolyn Anne Blessing on behalf of TEVA Neuroscience, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Yeda Research and Development Co. Ltd. (Blessing, Carolyn) |
Filing 11 NOTICE OF APPEARANCE by Patrice Polyxene Jean on behalf of TEVA Neuroscience, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Yeda Research and Development Co. Ltd. (Jean, Patrice) |
Filing 10 NOTICE OF APPEARANCE by William G. James, II on behalf of TEVA Neuroscience, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Yeda Research and Development Co. Ltd. (James, William) |
Filing 9 NOTICE OF APPEARANCE by Elizabeth J. Holland on behalf of TEVA Neuroscience, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Yeda Research and Development Co. Ltd. (Holland, Elizabeth) |
Filing 8 NOTICE OF APPEARANCE by Steven Jeffrey Lee on behalf of TEVA Neuroscience, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Yeda Research and Development Co. Ltd. (Lee, Steven) |
|
|
|
Filing 4 NOTICE OF CASE ASSIGNMENT to Judge Barbara S. Jones. Judge Unassigned is no longer assigned to the case. (ldi) |
Magistrate Judge Andrew J. Peck is so designated. (ldi) |
CASE ACCEPTED AS RELATED. Create association to 1:09-cv-10112-BSJ. Notice of Assignment to follow. (ldi) |
Filing 3 RULE 7.1 CORPORATE DISCLOSURE STATEMENT. Identifying Yeda Trust as Corporate Parent. Document filed by Yeda Research and Development Co. Ltd..(rdz) (ama). |
Filing 2 RULE 7.1 CORPORATE DISCLOSURE STATEMENT. Identifying Orvet UK Unlimited, Teva Pharmaceuticals Holdings Cooperative U.A.. Ivax LLC fka IVAX Corporation, Teva Pharmaceuticals Europe, B.V., Teva Pharmaceuticals Ltd.Teva Pharmaceuticals USA, Inc. as Corporate Parent. Document filed by TEVA Neuroscience, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc..(rdz) (ama). |
Filing 1 COMPLAINT against MYLAN Inc., MYLAN Pharmaceuticals Inc., Natco Pharma Ltd.. (Filing Fee $ 350.00, Receipt Number 915557)Document filed by Teva Pharmaceuticals USA, Inc., Teva Pharmaceutical Industries Ltd., Yeda Research and Development Co. Ltd., TEVA Neuroscience, Inc..(rdz) Modified on 9/23/2010 (rdz). (Additional attachment(s) added on 11/5/2010: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D) (ama). |
Filing 1 COMPLAINT against MYLAN Inc., MYLAN Pharmaceuticals Inc., Natco Pharma Ltd.. (Filing Fee $ 350.00, Receipt Number 915557)Document filed by Teva Pharmaceuticals USA, Inc., Teva Pharmaceutical Industries Ltd., Yeda Research and Development Co. Ltd., TEVA Neuroscience, Inc..(rdz) Modified on 9/23/2010 (rdz). (Additional attachment(s) added on 11/5/2010: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D) (ama). |
SUMMONS ISSUED as to MYLAN Inc., MYLAN Pharmaceuticals Inc., Natco Pharma Ltd.. (rdz) |
Case Designated ECF. (rdz) |
Mailed notice to Commissioner of Patents and Trademarks to report the filing of this action. (rdz) |
CASE REFERRED TO Judge Barbara S. Jones as possibly related to 09-cv-10112. (rdz) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the New York Southern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.